Although important to investigate disease mechanisms of CHMP2B-FTD, these studies were performed in murine models and using overexpression or depletion of CHMP2B protein levels, which do not resemble pathophysiology in patients. This evidence concerns the gene CHMP2B and frontotemporal dementia.